- Report
- August 2024
- 149 Pages
Global
From €2862EUR$2,999USD£2,398GBP
- Report
- July 2024
- 175 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- January 2025
- 184 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- January 2025
Global
From €18610EUR$19,500USD£15,593GBP
- Report
- April 2024
- 554 Pages
Global
From €9539EUR$9,995USD£7,992GBP
- Report
- June 2024
- 100 Pages
North America
From €5679EUR$5,950USD£4,758GBP
- Report
- January 2025
- 78 Pages
Africa, Middle East
From €2815EUR$2,950USD£2,359GBP
- Report
- January 2025
- 99 Pages
Asia Pacific
From €3293EUR$3,450USD£2,759GBP
- Report
- January 2025
- 95 Pages
North America
From €2815EUR$2,950USD£2,359GBP
- Report
- October 2023
- 174 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- October 2023
- 146 Pages
Global
From €3367EUR$3,528USD£2,821GBP
€3961EUR$4,150USD£3,318GBP
- Report
- January 2025
- 78 Pages
From €2815EUR$2,950USD£2,359GBP
- Report
- June 2023
- 234 Pages
Global
From €4581EUR$4,800USD£3,838GBP
- Report
- November 2022
- 50 Pages
Brazil
From €2147EUR$2,250USD£1,799GBP
- Report
- November 2022
- 50 Pages
Australia
From €2147EUR$2,250USD£1,799GBP
- Report
- November 2022
- 50 Pages
Japan
From €2147EUR$2,250USD£1,799GBP
- Report
- November 2022
- 50 Pages
Spain
From €2147EUR$2,250USD£1,799GBP
- Report
- November 2022
- 50 Pages
France
From €2147EUR$2,250USD£1,799GBP
- Report
- November 2022
- 50 Pages
Germany
From €2147EUR$2,250USD£1,799GBP
- Report
- November 2022
- 50 Pages
Mexico
From €2147EUR$2,250USD£1,799GBP

Stationary oxygen concentrators are medical devices designed for patients who require supplemental oxygen due to respiratory disorders such as COPD (Chronic Obstructive Pulmonary Disease), asthma, or sleep apnea. These devices work by filtering and concentrating oxygen from ambient air, providing patients with higher levels of oxygen than are naturally occurring. Unlike portable oxygen concentrators, stationary models are designed for home use rather than on-the-go mobility. They are typically larger, more robust, and can deliver higher flows of oxygen, making them suitable for patients with more intensive oxygen requirements, especially those who need continuous delivery of oxygen for extended periods.
Stationary oxygen concentrators are classified as durable medical equipment (DME) and are often covered under many health insurance plans with an appropriate prescription from a healthcare provider. The market for these concentrators includes a range of devices with varying flow rates, oxygen concentration levels, sizes, and capabilities to address different patient needs. Advancements in technology have made these devices more energy-efficient, quieter, and user-friendly.
Several companies are prominent in the stationary oxygen concentrators market, including Invacare, Philips Respironics, AirSep, Inogen, and DeVilbiss Healthcare. These manufacturers are known for their contributions to respiratory care and continue to develop and improve oxygen therapy solutions with a focus on enhancing patient quality of life and compliance with therapy. Show Less Read more